These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26561843)

  • 1. Bone markers in craniofacial bone deformations and dysplasias.
    Seifert M; Nelke KH; Noczyńska A; Łysenko L; Kubacka M; Gerber H
    Postepy Hig Med Dosw (Online); 2015 Oct; 69():1176-81. PubMed ID: 26561843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Paget's disease: case report].
    Wegierska M; Ignaczak P; Zalewska J; Jeka S
    Ann Acad Med Stetin; 2011; 57(3):64-9; discussion 69. PubMed ID: 23383549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paget's disease with craniofacial and skeletal bone involvement.
    Rai NP; Anekar J; Mustafa SM; Devang Divakar D
    BMJ Case Rep; 2016 Sep; 2016():. PubMed ID: 27587747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.
    Alvarez L; Peris P; Guañabens N; Vidal S; Ros I; Pons F; Filella X; Monegal A; Muñoz-Gomez J; Ballesta AM
    Arthritis Rheum; 2003 Mar; 48(3):824-8. PubMed ID: 12632438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paget's disease of bone, osteogenesis imperfecta, and fibrous dysplasia.
    Smith R
    Br Med J; 1977 Feb; 1(6057):365-7. PubMed ID: 837101
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical markers of bone turnover in Paget's disease.
    Russell RG; Beard DJ; Cameron EC; Douglas DL; Forrest AR; Guilland-Cumming D; Paterson AD; Poser J; Preston CJ; Milford-Ward A; Woodhead S; Kanis JA
    Metab Bone Dis Relat Res; 1981; 3(4-5):255-62. PubMed ID: 6220191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers of bone turnover in Paget's disease of bone.
    Eastell R
    Bone; 1999 May; 24(5 Suppl):49S-50S. PubMed ID: 10321928
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrous Dysplasia, Paget's Disease of Bone, and Other Uncommon Sclerotic Bone Lesions of the Craniofacial Bones.
    Van de Voorde N; Mortier GR; Vanhoenacker FM
    Semin Musculoskelet Radiol; 2020 Oct; 24(5):570-578. PubMed ID: 33036044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human calcitonin in the treatment of Paget's bone disease.
    Woodhouse NJ; Bordier P; Fisher M; Joplin GF; Reiner M; Kalu DN; Foster GV; MacIntyre I
    Lancet; 1971 Jun; 1(7710):1139-43. PubMed ID: 4102856
    [No Abstract]   [Full Text] [Related]  

  • 10. Paget's disease and fibrous dysplasia.
    Wallach S
    Curr Opin Rheumatol; 1991 Jun; 3(3):472-80. PubMed ID: 1883702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC; Harrison JE; Wilson DR
    Can Med Assoc J; 1977 Nov; 117(9):1031-4. PubMed ID: 562231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How to evaluate the activity of Paget's disease in clinical practice and which patients should be treated?].
    Reiner JC; Bontoux-Carre E; Seret P; Villayleck S
    Rev Rhum Mal Osteoartic; 1984 Oct; 51(9):463-8. PubMed ID: 6505596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic salmon calcitonin. Treatment of Paget's disease and osteogenesis imperfecta.
    Goldfield EB; Braiker BM; Prendergast JJ; Kolb FO
    JAMA; 1972 Sep; 221(10):1127-9. PubMed ID: 4679000
    [No Abstract]   [Full Text] [Related]  

  • 14. Remissions in Paget's disease produced by human synthetic calcitonin (calcitonin M).
    Woodhouse NJ; Reiner M; Kalu DN; Galante L; Joplin GF; MacIntyre I
    Clin Sci; 1970 Sep; 39(3):9P-10P. PubMed ID: 5459177
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.
    Alvarez L; Peris P; Pons F; Guañabens N; Herranz R; Monegal A; Bedini JL; Deulofeu R; Martínez de Osaba MJ; Muñoz-Gómez J; Ballesta AM
    Arthritis Rheum; 1997 Mar; 40(3):461-8. PubMed ID: 9082934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal turnover and total body elemental composition during extended calcitonin treatment of Paget's disease.
    Wallach S; Avramides A; Flores A; Bellavia J; Cohn S
    Metabolism; 1975 Jun; 24(6):745-53. PubMed ID: 1128238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
    Rashid M; Khairi A; Johnston C
    Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic disorders and bone affecting the craniofacial skeleton.
    Chacon GE; Ugalde CM; Jabero MF
    Oral Maxillofac Surg Clin North Am; 2007 Nov; 19(4):467-74, v. PubMed ID: 18088898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paget disease of the skeleton. Internal medicine aspects].
    Ziegler R; Baldauf G
    Radiologe; 1984 Sep; 24(9):401-7. PubMed ID: 6238341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paget's disease of the skeleton].
    Ziegler R
    Internist (Berl); 1990 Dec; 31(12):763-8. PubMed ID: 2289866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.